中国女性PGS周期中外源性促性腺激素剂量与囊胚非整倍体率或活产率无关
该回顾性研究分析了中国2013至2017年1088个PGS周期和3219个胚胎,按促性腺激素总剂量(<1500、1500-3000、>3000 IU)分层。校正混杂因素后,促性腺激素剂量与囊胚非整倍体率及单囊胚冷冻移植后的活产率均无显著关联。
要点
- 促性腺激素总剂量与囊胚非整倍体率无显著关联。
- 促性腺激素总剂量与单囊胚冷冻移植活产率无显著关联。
- 高龄女性(≥35岁)各剂量组非整倍体率无显著差异(P=0.86)。
核心结论
- 在中国女性PGS周期中,外源性促性腺激素总剂量与囊胚非整倍体率或活产率无显著关联。
研究设计与样本
- 回顾性研究,分析中国2013至2017年1088个PGS周期和3219个胚胎,采用array-CGH检测,纳入944名接受COH的女性。
主要发现
- 年轻女性(<35岁,537个PGS周期)按促性腺激素剂量分层,非整倍体发生率为36.9%至43.4%。
- 高龄女性(≥35岁,551个PGS周期)各剂量组非整倍体率:<1500 IU为58.0%,1500-3000 IU为59.8%,>3000 IU为59.8%(P=0.86)。
- 单囊胚冷冻移植后的活产率与促性腺激素剂量无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 局限性包括回顾性研究设计。
- 局限性包括纳入患者的异质性。
- array-CGH可能无法正确识别嵌合体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is the total dose of exogenous gonadotropins associated with blastocyst aneuploidy or live-birth rates in PGS cycles in Chinese women? SUMMARY ANSWER: The total dose of exogenous gonadotropins is not significantly associated with blastocyst aneuploidy or live-birth rates in PGS cycles in Chinese women. WHAT IS KNOWN ALREADY: The administration of gonadotropins in ovarian stimulation leads to supraphysiological steroid concentrations compared with those seen during natural cycles. The rate of euploid blastocytes is negatively associated with female age. STUDY DESIGN, SIZE, DURATION: This is a retrospective study using anonymised data on PGS cycles performed in China from 2013 to 2017. Data from 1088 PGS cycles and 3219 embryos were analysed by array-comparative genomic hybridization (array-CGH). PARTICIPANTS/MATERIALS, SETTING, METHODS: The study included 944 women who underwent PGS cycles with COH. All cycles were analysed by the total dose of exogenous gonadotropins (<1500, 1500-3000 and >3000 IU), patient age (<35 and ≥35 y.o.) and number of oocytes retrieved (1-5, 6-10, 11-15 and >15 oocytes). MAIN RESULTS AND THE ROLE OF CHANCE: In the group of younger women (<35 y.o., 537 PGS cycles), the incidence of aneuploidy ranged from 36.9 to 43.4% when data was stratified by gonadotropins dose. After adjusting for confounding factors, the dose of exogenous gonadotropins was not associated with the blastocyst aneuploidy rate. Similar results were shown in the group of women with advanced maternal age (≥35 y.o., 551 PGS cycles), with no difference in the rate of blastocyst aneuploidy among different gonadotropins dose groups (<1500 IU, 58.0%; 1500-3000 IU, 59.8%; and >3000 IU, 59.8%; P = 0.86). The live-birth rates after single cryopreserved blastocyst transfers were also not significantly associated with the gonadotropins dose. LIMITATIONS, REASONS FOR CAUTION: Limitations include the retrospective study design and the heterogeneity of the included patients. Additionally, array-CGH may not be able to correctly identify mosaicism. WIDER IMPLICATIONS OF THE FINDINGS: The finding that gonadotropin dosage is not associated with embryonic aneuploidy or live-birth rates in Chinese women suggests that the high doses of gonadotropins used in ART cycles may be safe. The findings are consistent with those of prior studies in other populations. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the National Natural Science Foundation of China (81671522) and National Key Research and Development Program of China (2016YFC1000202). TRIAL REGISTRATION NUMBER: N/A.
引用
- Wu Q, Li H, Zhu Y, et al. Dosage of exogenous gonadotropins is not associated with blastocyst aneuploidy or live-birth rates in PGS cycles in Chinese women. Hum Reprod. 2018. PMID: 30137360. doi:10.1093/humrep/dey270
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。